Search

everythinglearnresearchcommunity

for

Search:↓

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Loss of oil glands and inflammation might contribute to the development of scarring hair loss.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

People with non-scarring hair loss have higher levels of DKK-1, a protein linked to hair growth, than those with scarring hair loss or no hair loss.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A gluten-free diet does not help hair regrowth in celiac disease patients with alopecia areata.

Better hair loss models needed for research.

Eccrine gland activity may be linked to alopecia areata.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Early intervention and patient education are crucial for managing alopecia areata.

Low levels of zinc and ferritin may be linked to the severity of alopecia areata in Iraqi patients.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

More plasma leptin means higher baldness risk in men.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Reduced Stx17 expression may contribute to Alopecia Areata.

Etanercept may not prevent alopecia areata from coming back.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.